
PTCL demands swift approval of merger
Pakistan Telecommunication Company Limited (PTCL) and Ufone 4G President and Group Chief Executive Officer Hatem Bamatraf has called for speedy approval of the PTCL-Telenor merger transaction and warned that the amalgamation agreement may be affected due to certain timelines.
Talking to media on Monday, the CEO said that they had submitted all documents to the Competition Commission of Pakistan (CCP) pertaining to the merger. "We are surprised over the delay in the transaction for the last one year," he said, adding that Etisalat had been engaging in such transactions in other countries, which did not face such delay.
He pointed out that there were certain timelines in the transaction agreement that could affect the PTCL-Telenor merger.
Another PTCL official said that they were expecting further growth in PTCL following its merger with Telenor.
Hatem Bamatraf called unfair the delay on the part of competition body in granting approval to the merger with Telenor Pakistan. "We are waiting for the approval and are surprised over the delay; it should not have taken place," he said while responding to a query from the media.
On the occasion, the PTCL management presented financial results for the first quarter of calendar year 2025.
The company CEO said that PTCL had compiled documents for the CCP and the announcement of the decision was critical. He even referred to the investment made by Etisalat in Pakistan and other markets where the UAE-based company was operating.
Bamatraf added that if the required permission from the CCP was not received in time, the loan agreement between PTCL and the International Finance Corporation – a member of the World Bank group – might not be completed.
The financial results for the period from January-March 2025 showed that the company maintained its loss-making track despite a 22% revenue growth during the quarter.
The revenue of the PTCL group in the three months was Rs61.85 billion, but the group faced a net loss of Rs3.97 billion. The three main entities of the PTCL group were PTCL, Ufone and Ubank.
The key reason for the continuous loss incurred by PTCL was the financial condition of Ufone, which was in the red, despite a 21% revenue increase in the first three months of 2025. However, PTCL made a net profit of Rs1.17 billion.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Recorder
17 hours ago
- Business Recorder
CAT upholds CCP decision, confirms pharma co misled hospitals by false marketing
ISLAMABAD: The Competition Appellate Tribunal (CAT) has upheld a significant decision by the Competition Commission of Pakistan (CCP), confirming that a pharmaceutical company misled hospitals by falsely marketing a life-saving product for kidney patients. The Tribunal dismissed the appeal of 3N LIFEMED Pharmaceuticals and endorsed the Commission's finding of deceptive marketing—though it reduced the monetary penalty from Rs20 million to Rs2 million. The CCP had received a formal complaint from M/s Renacon Pharma Limited, which accused 3N LIFEMED of using fake quality certifications to market Haemodialysis Concentrate, a crucial product used in the treatment of kidney failure. The CCP's investigation revealed that 3N LIFEMED had falsely claimed its product was certified with Conformité Européene (CE) and Quality Management System (QMS) marks, obtained from a non-accredited firm based in Islamabad. These certifications, although voluntary under Pakistani laws, are widely seen as benchmarks of quality and are often required in public procurement tenders. The misleading claims were found to have misinformed hospitals and patients, creating a false impression of superior safety and efficacy in a sensitive market segment. Haemodialysis Concentrate is classified as a medical device by the Drug Regulatory Authority of Pakistan (DRAP) and is used to create dialysis fluid, which must closely match the patient's natural blood chemistry to prevent complications. During the CAT proceedings, 3N LIFEMED's counsel argued that the company ceased using the disputed markings after receiving a show-cause notice from CCP and insisted that the product was DRAP-approved. They also attempted to shift blame to SIMS-AGS, the Islamabad-based company that issued the certifications, whose international accreditation was revoked in 2020. However, CCP's counsel countered that 3N LIFEMED, as a pharmaceutical company, should have known that such certifications cannot simply be purchased but must be earned through rigorous inspections. The Tribunal agreed with CCP's position, observing that while such certifications may not be legally mandatory, they influence procurement decisions and public trust—and misusing them constitutes deception. In light of 3N LIFEMED's financial capacity, the Tribunal reduced the penalty to Rs2 million but imposed a strict compliance deadline: failure to pay within ten days will attract an additional fine of Rs100,000 per day. Copyright Business Recorder, 2025


Express Tribune
18 hours ago
- Express Tribune
Pakistan-UAE JMC to be held in Abu Dhabi
Deputy Prime Minister Senator Mohammad Ishaq Dar on Friday chaired a high-level meeting to review preparations for the upcoming 12th session of the Pakistan-UAE Joint Ministerial Commission (JMC) scheduled to be held in Abu Dhabi. The meeting was attended by SAPM to DPM Office, federal secretaries of economic affairs, commerce, maritime affairs, interior, inter-provincial coordination, national heritage, and health, along with senior officials from relevant ministries and departments, including MoFA, overseas Pakistanis, finance, railways, defence, and tourism.


Business Recorder
18 hours ago
- Business Recorder
Pakistan, UAE agree to convene JMC moot in Abu Dhabi
ISLAMABAD: Pakistan and the United Arab Emirates (UAE) have agreed to convene a meeting of Joint Ministerial Commission (JMC) in Abu Dhabi. Both the countries have showed willingness in this regard during Prime Minister Shehbaz Sharif's day-long visit to UAE on June 12. However, dates for holding the Pak-UAE JMC are being finalised. Shehbaz, Abu Dhabi ruler discuss regional and global issues Meanwhile, Deputy Prime Minister/Foreign Minister Ishaq Dar chaired a high-level meeting on Friday at the Ministry of Foreign Affairs (MOFA) to review preparations for the upcoming 12th session of the Pakistan-UAE Joint Ministerial Commission in Abu Dhabi. The meeting was attended by SAPM to DPM Office, federal secretaries of Economic Affairs, Commerce, Maritime Affairs, Interior, Inter-Provincial Coordination, National Heritage, and Health, along with senior officials from relevant ministries and concerned departments, including MoFA, overseas Pakistanis, Finance, Railways, Defence, and Tourism. Discussions focused on advancing key bilateral initiatives, formalising collaboration in existing sectors, exploring new avenues for cooperation, and attracting mutually-beneficial UAE investments in priority areas, the Foreign Office spokesperson said. The DPM/FM reiterated Pakistan's firm commitment to strengthening Pakistan-UAE economic and trade relations. The UAE is Pakistan's third largest trading partner after China and the United States. The UAE is also home to over one million Pakistani expatriates and the second source of major remittances to Pakistan. Currently, according to a senior official trade volume between Pakistan and the UAE crossed over USD 10.9 billion. Copyright Business Recorder, 2025